COVID-19 Vaccine (Pfizer-BioNTech)
- 1 Background
- 2 Clinical Features
- 3 Administration
- 4 Adult Dosing
- 5 Pediatric Dosing
- 6 Special Populations
- 7 Contraindications
- 8 Adverse Reactions
- 9 Pharmacology
- 10 Mechanism of Action
- 11 Comments
- 12 See Also
- 13 External Links
- 14 References
The Pfizer-BioNTech COVID-19 vaccine is an mRNA based vaccine which is approved in the United States to prevent symptomatic COVID-19 infection. The Pfizer-BioNTech was the first COVID-19 vaccine to be approved for distribution in the United States, and it was granted Emergency Use Authorization by the United States Food and Drug Administration (FDA) on 11 December 2020.
The approved vaccine dosing regimen is an intramuscular injection given as two doses, 30 μg each, administered 21 days apart. The vaccine is approved for individuals 16 years of age and older.
The vaccine is intended to prevent the COVID-19 illness, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The Pfizer-BioNTech vaccine targets the SARS-CoV-2 spike glycoprotein (S).
- Type: SARS-CoV-2 spike glycoprotein (S) antigen encoded by RNA and formulated in lipid nanoparticles (LNPs).
- Dosage Forms: 2 doses of 30 μg each, administered 21 days apart.
- Routes of Administration: Intramuscular
- Common Trade Names: Pfizer-BioNTech COVID-19 Vaccine, Pfizer Vaccine
The adult dosing of the vaccine is 2 doses of 30 μg each, administered 21 days apart.
The Pfizer-BioNTech COVID-19 vaccines has only been approved for individuals aged 16+. However, the dosing in individuals aged 16 and 17 is the same as the adult dosing of the vaccines.
It is unclear as to the effect of the vaccine in pregnant women, as Pregnancy was an exclusion criteria from the phase 3 clinical trial for this vaccine.
- Allergy to class/drug
Mechanism of Action
- COVID-19: Epidemiology and pathophysiology
- COVID-19: Example hospital protocols
- COVID-19: Hospital preparedness
- COVID-19: Management of recovered patients
- COVID-19: Medication therapy
- COVID-19: Resource scarcity
- COVID-19: Testing and surveillance
- COVID-19 (peds)
- COVID-19 Vaccine (Moderna)
- COVID-19 Vaccine (Pfizer-BioNTech)
- COVID-19 in pregnancy
- COVID-19 vaccines